Trial intelligence / Profile preview

Perindopril and leucine to improve muscle function in older people

2014-003455-61Phase 4Terminated

Sponsor
Tayside Medical Science Centre
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of perindopril and l-leucine in Sarcopenia (4 arms), sponsored by Tayside Medical Science Centre. Primary endpoint: Short Physical Performance Battery score at 12 months. Started Mar 2015; status: terminated.

02

Drugs

perindoprill-leucine
03

Conditions

Sarcopenia

Beyond the preview

Go deeper on 2014-003455-61.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003455-61.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call